Musto, P. Et Al. 2024. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry. Hematological Oncology , vol.42, no.1 .

Musto, P., Salmanton-García, J., Sgherza, N., Bergantim, R., Farina, F., Glenthøj, A., ... CENGİZ SEVAL, G.(2024). Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry. Hematological Oncology , vol.42, no.1.

Musto, Pellegrino Et Al. "Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry," Hematological Oncology , vol.42, no.1, 2024

Musto, Pellegrino Et Al. "Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry." Hematological Oncology , vol.42, no.1, 2024

Musto, P. Et Al. (2024) . "Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry." Hematological Oncology , vol.42, no.1.

@article{article, author={Pellegrino Musto Et Al. }, title={Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry}, journal={Hematological Oncology}, year=2024}